Joint Replacement Medication Guide for Personal Injury Cases

James Wong — Founder & Pharmacist, LienScripts | March 29, 2026 | 7 min read

Joint replacement surgery after a traumatic accident involves extensive medication management — pre-surgical optimization, post-operative pain control, DVT prophylaxis, and months of rehabilitation pharmaceuticals. Learn the full medication arc and how a pharmacy lien documents every phase.

Joint Replacement Medication Guide for Personal Injury Cases

Joint replacement surgery following a traumatic accident requires a comprehensive medication protocol spanning pre-surgical optimization, intra-operative pharmaceuticals, post-operative pain management, deep vein thrombosis prophylaxis, infection prevention, and months of rehabilitation-phase medications. For personal injury attorneys, the pharmaceutical record from a joint replacement case is among the most detailed and well-documented medication timelines available — each drug prescribed serves a specific clinical purpose that correlates directly to injury severity and recovery complexity.

• Pre-surgical medications include blood thinners management, pre-operative antibiotics, multimodal pain pre-medication (gabapentin, celecoxib, acetaminophen), and medical optimization of comorbidities
• Post-operative medications span opioid analgesics, NSAIDs, anticoagulants for DVT prevention (enoxaparin, rivaroxaban, apixaban), antibiotics, anti-nausea agents, and stool softeners
• DVT prophylaxis alone generates 2-6 weeks of documented anticoagulant fills — medications prescribed specifically because the surgical procedure created a life-threatening clot risk
• Rehabilitation-phase medications (months 2-6+) include anti-inflammatories, sleep aids, nerve pain agents, and muscle relaxants to support aggressive physical therapy
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that organizes the entire joint replacement medication timeline into a single chronological document for demand packages

Why Traumatic Joint Replacement Carries Greater Case Value

Not all joint replacements are equal in a personal injury context. An elective joint replacement for age-related arthritis follows a predictable, planned pathway. A traumatic joint replacement — where the accident caused the fracture or joint destruction that necessitated the surgery — is a fundamentally different clinical event.

According to James Wong, PharmD, founder of LienScripts, "Traumatic joint replacement patients are typically younger, have no prior joint disease, and face a recovery complicated by the acute injury itself. The medication profile reflects this complexity — it is significantly more extensive than an elective replacement, and that difference is visible in the pharmacy record."

Common traumatic mechanisms leading to joint replacement include comminuted fractures of the femoral head or acetabulum (hip replacement), tibial plateau fractures with articular destruction (knee replacement), and proximal humerus fractures beyond surgical repair (shoulder replacement).

[!KEY] The medication record from a traumatic joint replacement documents not just pain management but life-safety medications — anticoagulants to prevent fatal blood clots, antibiotics to prevent prosthetic joint infection, and multimodal protocols to manage surgical trauma. Each prescription category carries independent evidentiary weight.

Pre-Surgical Phase: Medical Optimization

The pre-surgical medication period — typically 2-6 weeks before the scheduled surgery — involves pharmaceutical preparation for the procedure.

Blood thinner management — patients on anticoagulants or antiplatelet agents must discontinue them before surgery, sometimes with bridging therapy (enoxaparin injections). This management generates its own pharmacy records.

Pre-operative multimodal medications (ERAS protocol):

• Celecoxib 200-400 mg — administered the morning of surgery or the night before to reduce post-operative inflammation
• Gabapentin 300-600 mg — a single pre-operative dose to reduce central sensitization and post-operative opioid requirements
• Acetaminophen 1000 mg — scheduled pre-operatively as part of the non-opioid analgesic foundation
• Scopolamine patch — applied behind the ear before surgery to reduce post-operative nausea

Pre-operative antibiotics — cefazolin IV is administered within 60 minutes of incision. While the IV dose is billed through the surgical facility, post-operative oral antibiotics may be filled through the pharmacy lien.

Post-Operative Phase: Days 1-14

The immediate post-operative period is the most medication-intensive phase of joint replacement recovery.

Opioid analgesics remain the standard for managing acute post-surgical pain:

• Oxycodone 5-10 mg every 4-6 hours as needed — the most commonly prescribed post-joint replacement opioid
• Hydromorphone (Dilaudid) — for patients with severe pain or oxycodone intolerance
• Tramadol — increasingly used as a step-down from stronger opioids beginning around post-operative day 3-5

DVT prophylaxis is critical and generates weeks of documented pharmaceutical therapy:

• Rivaroxaban (Xarelto) 10 mg daily — an oral anticoagulant prescribed for 14 days (knee) or 35 days (hip) after joint replacement
• Apixaban (Eliquis) 2.5 mg twice daily — an alternative oral anticoagulant with a similar duration
• Enoxaparin (Lovenox) injections — subcutaneous injections administered daily or twice daily for patients requiring injectable anticoagulation
• Aspirin 81-325 mg — used in some protocols as extended DVT prophylaxis following the primary anticoagulant course

[!TIP] DVT prophylaxis medications are prescribed specifically because the joint replacement surgery created a risk of life-threatening blood clots. In the demand package, frame these medications not as routine pills but as life-safety pharmaceuticals necessitated by the surgical trauma the defendant's actions caused.

Anti-nausea medications — ondansetron (Zofran), promethazine, or metoclopramide — are commonly prescribed for the first week to manage opioid-induced and post-anesthetic nausea.

Stool softeners and bowel management — docusate sodium and polyethylene glycol are prescribed to counteract opioid-induced constipation. While seemingly minor, bowel complications from opioid use can become medically significant if not managed.

Ice therapy and compression — a prescription cryotherapy unit may be dispensed through durable medical equipment channels coordinated with the pharmacy lien.

Rehabilitation Phase: Weeks 3 Through Month 6

Physical therapy after joint replacement is aggressive and prolonged, and the medication protocol supports the patient through increasingly demanding rehabilitation milestones.

NSAIDs for PT-related inflammation — meloxicam, diclofenac, or celecoxib are prescribed for ongoing inflammation control as physical therapy pushes the joint through range-of-motion exercises. The shift from opioids to NSAIDs as the primary analgesic documents recovery progression.

Muscle relaxants — cyclobenzaprine or tizanidine for muscle guarding and spasm that develops around the surgical site during aggressive PT. Periprosthetic muscle spasm can significantly limit rehabilitation progress.

Neuropathic agents — gabapentin or pregabalin may be introduced if the patient develops nerve pain around the surgical site. Cutaneous nerve damage during the surgical approach is common, producing numbness, burning, or hypersensitivity that requires pharmacological management.

Sleep medications — trazodone, hydroxyzine, or low-dose amitriptyline address the persistent sleep disruption caused by surgical site discomfort, positional limitations, and the physiological stress of recovery.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The rehabilitation-phase pharmacy record shows a patient taking multiple medications specifically to participate in physical therapy. Each fill is a timestamp proving the patient was actively engaged in recovery — which counters any defense argument of non-compliance or malingering."

[!KEY] The joint replacement medication record serves a dual evidentiary purpose: it documents the severity of the original injury (the accident destroyed the joint beyond repair) and the burden of the treatment required (months of multi-drug pharmaceutical management including life-safety anticoagulation). Both dimensions support settlement value.

Long-Term Considerations: Month 6 and Beyond

Joint replacement patients face permanent pharmaceutical considerations:

Antibiotic prophylaxis for dental procedures — for the first year (and potentially longer), joint replacement patients must take antibiotics before dental work to prevent prosthetic joint infection. This is a lifelong consideration that documents permanent alteration of the patient's medical baseline.

Ongoing anti-inflammatory management — many traumatic joint replacement patients require intermittent NSAID use for the life of the prosthesis, particularly during weather changes, activity increases, or when the prosthesis settles.

Future revision surgery — traumatic joint replacements in younger patients have a statistical probability of requiring revision surgery within 15-20 years. While this is not reflected in the current pharmacy record, it represents a future medical cost that the medication timeline supports.

The MERIT Report for Joint Replacement Cases

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. For joint replacement cases, the MERIT report organizes the extensive pre-surgical, post-surgical, DVT prophylaxis, and rehabilitation medication records into a coherent narrative that demonstrates the full scope of pharmaceutical treatment necessitated by the traumatic injury.

Related Resources

• Ankle Fracture Surgery Medications and Pharmacy Liens
• Pain Management After a Car Accident
• MERIT Report: What It Is and Why It Matters